NEW YORK (
) -- Shares of
) have taken a tremendous swing upward. The stock is trading at $2.65 as of 3:56 p.m. ET, 35.9% above Monday's closing price of $1.95. Volume is at 1.1 million, 0.8 times the daily average of 1.5 million.
Neoprobe has a market cap of $216.7 million and is part of the
industry. Shares are down 5.3% year to date as of the close of trading on Monday.
Neoprobe Corporation, a biomedical company, engages in the development and commercialization of surgical and diagnostic oncology products that enhance patient treatment by meeting the critical decision making needs of physicians in the United States and internationally.
TheStreet Ratings rates Neoprobe as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full
for other stocks that are soaring today, or get investment ideas from our
Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from